Product Data Sheet

TZD18

Catalog No. A40193

main product photo
TZD18 is a potent dual agonist of PPARα and PPARγ, exhibiting IC50 values of 0.028 µM and 0.057 µM, respectively, while showing minimal activity toward PPARδ (>10 µM). This compound effectively reduces plasma glucose and triglyceride levels in diabetic mouse models. TZD18 holds promise for research into type 2 diabetes and related metabolic disorders.
Chemical Information
Catalog NumA40193
M. Wt477.57
FormulaC27H27NO5S
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.228577-00-2
Synonyms
SMILESO=C(SC1C2=CC=CC(OCCCOC3=CC=C(C=C3CCC)OC4=CC=CC=C4)=C2)NC1=O
Biological Activity
DescriptionTZD18 is a potent dual agonist of PPARα and PPARγ, exhibiting IC50 values of 0.028 µM and 0.057 µM, respectively, while showing minimal activity toward PPARδ (>10 µM). This compound effectively reduces plasma glucose and triglyceride levels in diabetic mouse models. TZD18 holds promise for research into type 2 diabetes and related metabolic disorders.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.